Lv5
938 积分 2023-04-23 加入
ZAP327 signaling domain–driven chimeric antigen receptor generates robust and long-term antitumor immunity in mouse models
8天前
已完结
DR5 CAR-NK cells demonstrate superior scalability and potent antitumor activity with favorable safety
8天前
已完结
Development of a high-affinity anti-ROR1 variable region for broad anti-cancer immunotherapy
8天前
已关闭
DR5 CAR-T cells target melanoma and suppress MDSCs with minimal toxicity
8天前
已完结
Downregulation of MICA/MICB improves cell persistence and clinical activity of NKG2DL CAR T-cells in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic neoplasia
8天前
已完结
Designing immunity with cytokines: A logic-based framework for programmable CAR therapies
8天前
已完结
NK cell adaptation in the tumor microenvironment: Insights for NK cell-based immunotherapy
9天前
已完结
Allogeneic stem cell-engineered EGFRvIII-specific CAR-NKT cells for treating glioblastoma with enhanced efficacy and safety
9天前
已关闭
Redefining Multiple Sclerosis with CAR-T Cell Therapy
12天前
已完结
THE INTERSECTION OF CAR-T IMMUNOTHERAPY WITH EMERGING TECHNOLOGIES
12天前
已完结
皖公网安备34019202002308
